Abstract
Purpose of Review
Vascular access and closure is a key part of endovascular procedures, and access site-related complications are an independent predictor of adverse procedural outcomes. The purpose of this review is to discuss the methods of vascular closure including manual compression, vascular closure devices (VCDs) for both arterial and venous arteriotomies, their mechanisms, and access site-related complications.
Recent Findings
Various VCDs have been approved over the last three decades. These devices have different mechanisms to achieve hemostasis and are generally categorized into active and passive approximators. Studies have largely found that they are non-inferior to manual compression.
Summary
Uncomplicated vascular closure is pertinent to avoid adverse procedure-related outcomes. The emergence of VCDs has reduced time to hemostasis, facilitating early ambulation and discharge and reducing hospitalization cost with comparable complication rate to manual compression. Nonetheless, they should be used in favorable vascular anatomy and are not intended to reduce complications.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Chiang A, Gada H, Kodali SK, Lee MS, Jeremias A, Pinto DS, et al. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv. 2014;83(5):721–26.
Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):196–02.
Chandrasekar B, Doucet S, Bilodeau L, Crepeau J, deGuise P, Gregoire J, et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv. 2001;52(3):289–95.
Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterizationsystematic review and meta-analysis. JAMA. 2004;291(3):350–7.
Bangalore S, Bhatt DL. Femoral arterial access and closure. Circulation. 2011;124(5):e147–56.
Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44(6):1200–9.
Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159(4):518–31.
Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014;312(19):1981–7.
Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, et al. Effectiveness of arterial closure devices for preventing complications with percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9(4):e003464.
Rao SV, Kaltenbach LA, Weintraub WS, Roe MT, Brindis RG, Rumsfeld JS, et al. Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA. 2011;306(13):1461–7.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention. Circulation. 2011;124(23):e574–e651.
Nash JE, Evans DG. The Angio-Seal™ hemostatic puncture closure device. Herz. 1999;24(8):597–606.
Hvelplund A, Jeger R, Osterwalder R, Bredahl M, Madsen JK, Jensen JS, et al. The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention. EuroIntervention. 2011;7(2):234–41.
Martin JL, Pratsos A, Magargee E, Mayhew K, Pensyl C, Nunn M, et al. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv. 2008;71(1):1–5.
Nelson PR, Kracjer Z, Kansal N, Rao V, Bianchi C, Hashemi H, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59(5):1181–93.
Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40(1):78–83.
Haulon S, Hassen Khodja R, Proudfoot CW, Samuels E. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. Eur J Vasc Endovasc Surg. 2011;41(2):201–13.
Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND ii) trials. Am J Cardiol. 2000;85(7):864–69.
Veasey RA, Large JK, Silberbauer J, Paul G, Taggu W, Ellery S, et al. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital–the SCOAST study. Int J Clin Pract. 2008;62(6):912–8.
Bavry AA, Raymond RE, Bhatt DL, Chambers CE, DeNardo AJ, Hermiller JB, et al. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device. J Invasive Cardiol. 2008;20(4):152–6.
Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C, Fearon W, et al. Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device. Circ Cardiovasc Interv. 2019;12(7):e007258.
•• van Wiechen Maarten P, Tchétché D, Ooms Joris F, Hokken Thijmen W, Kroon H, Ziviello F, et al. Suture- or plug-based large-bore arteriotomy closure. JACC Cardiovasc Interv. 2021;14(2):149–57. This is a recently published study comparing suture- and plug-based vascular closure devices in large-bore arteriotomy.
Wong SC, Gammon R, Bachinsky W, O’Shaughnessy C, Leimbach W, Bernardo N, et al. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of Closer(TM) VSS, a novel resorbable transfemoral vascular access sealing system. Catheter Cardiovasc Interv. 2017;90(5):798–805.
Hermiller JB, Leimbach W, Gammon R, Karas SP, Whitbourn RJ, Wong SC, et al. A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients. J Invasive Cardiol. 2015;27(3):129–36.
Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, et al. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (ensure’s vascular closure device speeds hemostasis trial). JACC Cardiovasc Interv. 2009;2(8):785–93.
Kara K, Mahabadi AA, Rothe H, Müller P, Krüger J, Neubauer H, et al. Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the angio-seal and proGlide. J Endovasc Ther. 2014;21(6):822–28.
Scheinert D, Sievert H, Turco MA, Schmidt A, Hauptmann KE, Mueller R, et al. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv. 2007;70(5):627–33.
Scott MC, Spencer HJ, Ali AT, Moursi MM, Escobar GA, Lyons LC, et al. Mynx vascular closure device in arterial endovascular procedures. Ann Vasc Surg. 2018;46:112–7.
O’Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. Circulation. 2012;126(14):1717–27.
Lata K, Kaki A, Grines C, Blank N, Elder M, Schreiber T. Pre-close technique of percutaneous closure for delayed hemostasis of large-bore femoral sheaths. J Interv Cardiol. 2018;31(4):504–10.
Thawabi M, Cohen M, Wasty N. Post-close technique for arteriotomy hemostasis after Impella removal. J Invasive Cardiol. 2019;31(6):E159.
Vinayakumar D, Kayakkal S, Rajasekharan S, Thottian JJ, Sankaran P, Bastian C. 24h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: an Indian experience. Indian Heart J. 2017;69(1):37–42.
Nagabandi ARS, Morgan LG, Kapoor D. Use of Vascade vascular closure system for venous hemostasis. Vasc Dis Manag. 2017;14(8):E171–3.
Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio David B, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures. JACC Clin Electrophysiol. 2020;6(1):111–24.
Aytemir K, Canpolat U, Yorgun H, Evranos B, Kaya EB, Şahiner ML, et al. Usefulness of ‘figure-of-eight’ suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2016;18(10):1545–50.
Traullé S, Kubala M, Doucy A, Quenum S, Hermida J-S. Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation. Europace. 2016;18(6):815–9.
Jensen CJ, Schnur M, Lask S, Attanasio P, Gotzmann M, Kara K, et al. Feasibility of the figure-of-8-suture as venous closure in interventional electrophysiology: one strategy for all? Int J Med Sci. 2020;17(7):965–9.
Halabi M, Ratnayaka K, Faranesh AZ, Chen MY, Schenke WH, Lederman RJ. Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation. J Am Coll Cardiol. 2013;61(16):1745–6.
Lederman RJ, Babaliaros VC, Greenbaum AB. How to perform transcaval access and closure for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015;86(7):1242–54.
Greenbaum AB, Babaliaros VC, Chen MY, Stine AM, Rogers T, O’Neill WW, et al. Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation. J Am Coll Cardiol. 2017;69(5):511–21.
• Rogers T, Greenbaum AB, Babaliaros VC, Stine AM, Khan JM, Schenke WH, Eng MH, Paone G, Leshnower BG, Satler LF, Waksman R. Dedicated closure device for transcaval access closure: from concept to first-in-human testing. JACC Cardiovasc Interv. 2019;12(21):2198–206. The manuscript provides insights into evolving transcaval access closure devices post-transcatheter aortic valve replacement.
Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009;74(1):64–73.
Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156–64.
Cox T, Blair L, Huntington C, Lincourt A, Sing R, Heniford BT. Systematic review of randomized controlled trials comparing manual compression to vascular closure devices for diagnostic and therapeutic arterial procedures. Surg Technol Int. 2015;27:32–44.
Biancari F, D’Andrea V, Marco CD, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159(4):518–31.
Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochr Datab System Rev. 2016;3:Cd009541.
•• Kennedy SA, Rajan DK, Bassett P, Tan KT, Jaberi A, Mafeld S. Complication rates associated with antegrade use of vascular closure devices: a systematic review and pooled analysis J Vasc Surg. 2021;73(2)722–30.e1. This is a recent review on complication rates of vascular closure devices.
Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, et al. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. J Invasive Cardiol. 2012;24(7):328–34.
Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2007;69(7):961–66.
Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–10; discussion 10–3.
Kolluri R, Fowler B, Nandish S. Vascular access complications: diagnosis and management. Curr Treat Options Cardiovasc Med. 2013;15(2):173–87.
Kelm M, Perings SM, Jax T, Lauer T, Schoebel FC, Heintzen MP, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol. 2002;40(2):291–7.
Prasad A, Compton PA, Prasad A, Roesle M, Makke L, Rogers S, et al. Incidence and treatment of arterial access dissections occurring during cardiac catheterization. J Interv Cardiol. 2008;21(1):61–6.
Messina LM, Brothers TE, Wakefield TW, Zelenock GB, Lindenauer SM, Greenfield LJ, et al. Clinical characteristics and surgical management of vascular complications in patients undergoing cardiac catheterization: interventional versus diagnostic procedures. J Vasc Surg. 1991;13(5):593–600.
Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 1992;69(1):63–8.
Author information
Authors and Affiliations
Contributions
Sukhdeep Bhogal conducted the literature search, performed data analysis, and drafted the manuscript. Ron Waksman critically revised the work.
Corresponding author
Ethics declarations
Ethics Approval
This manuscript is a review of the literature and therefore is exempted from ethical approval requirements.
Conflict of Interest
Ron Waksman reports serving on the advisory boards of Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, and Pi-Cardia Ltd.; being a consultant for Abbott Vascular, Biotronik, Boston Scientific, Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd., Swiss Interventional Systems/SIS Medical AG, Transmural Systems Inc., and Venous MedTech; receiving grant support from AstraZeneca, Biotronik, Boston Scientific, Chiesi, Medtronic, and Philips IGT; serving on the speakers bureau of AstraZeneca; and being an investor in MedAlliance and Transmural Systems Inc., outside the scope of the submitted work. Sukhdeep Bhogal has no competing interests to declare.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Interventional Cardiology
Rights and permissions
About this article
Cite this article
Bhogal, S., Waksman, R. Vascular Closure: the ABC’s. Curr Cardiol Rep 24, 355–364 (2022). https://doi.org/10.1007/s11886-022-01654-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-022-01654-z